ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Reuters Grp.

Reuters Grp. (RTR)

631.00
0.00
(0.00%)
Closed January 04 10:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
631.00
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
631.00
Open
-
Last Trade
(O)
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

RTR Latest News

Scheme of arrangement

RNS Number:5105S Reuters Group PLC 16 April 2008 16 April 2008 Reuters Group PLC Announcement of Court approval of the reduction of capital of Reuters Group PLC pursuant to the...

Rule 2.10 Announcement

RNS Number:5077S Reuters Group PLC 16 April 2008 Reuters Group PLC - Rule 2.10 Announcement 16 April 2008 Reuters Group PLC Disclosure in accordance with Rule 2.10 of the City...

Rule 8.3- Reuters group

RNS Number:4914S State Street Global Advisors 16 April 2008 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers...

Rule 8.3- Reuters Group Plc

RNS Number:4798S Credit Suisse Securities (Eur) Ltd 16 April 2008 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers...

Rule 8.3 - REUTERS GROUP

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing BARCLAYS PLC (Note...

EPT Disclosure

RNS Number:4695S UBS AG (EPT) 16 April 2008 FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING...

EPT Disclosure-Amendment

RNS Number:4679S Morgan Stanley Securities Limited 16 April 2008 AMENDMENT TO ANNOUNCEMENT 3586S RELEASED AT 11:15 ON 15 APRIL 2008 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS...

EPT Disclosure

RNS Number:4660S Morgan Stanley Securities Limited 16 April 2008 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING...

EPT Disclosure

RNS Number:4644S Citigroup Global Markets UK EqtyLtd 16 April 2008 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING...

EPT Disclosure

RNS Number:4572S UBS AG (EPT) 16 April 2008 FORM 38.5(b) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS BUT NOT DEALING IN A...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

RTR - Frequently Asked Questions (FAQ)

What is the current Reuters share price?
The current share price of Reuters is 631.00p
What is the 1 year trading range for Reuters share price?
Reuters has traded in the range of 0.00p to 0.00p during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
crescentmotor crescentmotor 36 seconds ago
Seems like a lot of silly effort for no impact on share price come Monday-Friday.

With AVXL's MAA being accepted and under review, a favorable/supportive peer review article about to be officially released in mass distribution, and presentations of OLE trial data at the prestigious JP
AVXL JPM
mauismart mauismart 2 minutes ago
I just bought a. 2000 Toyota echo with over 100k miles for only $1200 and she gets over 30 miles to the gallon. I saved my avxl share
AVXL
carvajal carvajal 2 minutes ago

Brian's ties to Brazil date back to 2021.

" style="font-size: 1em"#HUMBL continues to advance. Please do not mistake silence for weakness."

 
HMBL
shortridge3w shortridge3w 3 minutes ago
Regarding the 1.8 point difference of ADAS-cog13 between dosed and placebo, the worst estimate could be done by extending the dosed curve 4 months, which would result in 1 point increase. This can be verified with the open label extension data.
AVXL
Risk Risk 3 minutes ago
Yes Golf. I Agree, Just want to get out man break even if it's a possiblility???
Happy to hear you made it back on Quantum stocks.
AFFU
TURCH TURCH 3 minutes ago
Yup have Rr and krknf if u find any others let me know!


Regards
doccjc doccjc 4 minutes ago
Wonder if we'll get an update on Monday ?
First full week of trading since the India  human trials announcement 
Positive human trial results may cause the stock to run imo .
RDGL
theorysuit theorysuit 5 minutes ago
Immunomedics was $10B before Gilead bought them for Trodelvy. They paid $21B before it had FDA approval.

Wrong, IMMU already had accelerated approval in mTNBC by FDA, and had confirmatory data that was stopped early for hitting their pfs and OS endpoints to support full approval. A
NWBO
doccjc doccjc 6 minutes ago
Sure as hell feels different. Obgoing human trials , IDE about to be submitted .  We're about to find out if this works in humans as well as it does in animals. No reason it shouldn't .  Share price is about to take off imo . 
RDGL
StockItOut StockItOut 9 minutes ago
Bitcoin, for example, is not lawful money.

The Note is: money or shares or both. Standard.

You really are a nutjob.
XERI
againstallodds againstallodds 9 minutes ago
A/S tells you where JarHead is headed….
NBRI
blackhawks blackhawks 10 minutes ago
Curtain is still with us.

https://en.wikipedia.org/wiki/Jane_Curtin
getmoreshares getmoreshares 11 minutes ago
.0005 next!
KATX
StockItOut StockItOut 11 minutes ago
The Note is either/or you moron.
XERI
SSKILLZ1 SSKILLZ1 11 minutes ago
Mr. Sheep Picks

There will two Mr. Sheep this contest one with cash and one without. Hope this helps.
[pre]
38 Alias: MR. SHEEP

Symbol
1 $$
2 CCEL 4-3/4 Positions
3 ETCC
4 OPXS
5
ETCC VNDA
georgejjl georgejjl 11 minutes ago
Don't forger Ern Heaven from the Phase 2a trial.

https://www.youtube.com/watch?v=8orzf4UXNLA

Good luck and GOD bless,
AVXL
quester614 quester614 11 minutes ago
There is a reason the clause lawful money is in the Auctus loan. They were never going to sell 1 shares or OPTION. ANY DECENT LAWYER should know that a specific language is used for reasons in contracts.

LOLOLOLhttps://investorshub.advfn.com/uimage/uploads/2025/1/4/qwgpiScreenshot_20
XERI
Manspider Manspider 13 minutes ago
Foolish rabbit … tricks are for kids! :-D
ASII
jay_tee jay_tee 13 minutes ago
It's obvious you still believe in Santa if you really believe I'm a paid basher. I've never once bashed RNVA
RNVA
solong solong 14 minutes ago
Read all of the tweets from the company, they aren't going for Pink Current. Do you have any idea as to who is in charge? Read the company tweets.

They've laid out where this is heading and Pink Current is not the destination.
SYIN
imho imho 14 minutes ago
I have noticed that posts by Doc and Investor critiquing Blarcamisine, avoid comparisons to the MABs. They would be correct in stating that the MABs have nothing to do in assessing if Blarcamisine works (vs a placebo). That is the premise and the basis for their conclusions.

However,
AVXL

Your Recent History

Delayed Upgrade Clock